Skip to main content

Juan Marcos Gonzalez

Associate Professor in Population Health Sciences
Population Health Sciences
200 Morris Street, Durham, NC 27701
200 Morris Street, Durham, NC 27701

Selected Grants


FDA - BAA Clinical Evidence on the impact of osseointegrated limb prostheses

ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2023 - 2026

Preferences for Lung Cancer Therapies for Patients with Stage I-IIIB Lung Cancer

ResearchPrincipal Investigator · Awarded by LUNGevity Foundation · 2024 - 2025

Pain Management Decision Making in Advanced Kidney Disease

ResearchSignificant Contributor · Awarded by Regents of the University of Michigan · 2023 - 2025

CARE- Choices About Abortion CaRE Options

ResearchCollaborating Investigator · Awarded by Society of Family Planning Research Fund · 2023 - 2025

Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period

ResearchCo Investigator · Awarded by Food and Drug Administration · 2022 - 2024

Novel T2DM Therapies

ResearchPrincipal Investigator · Awarded by Fractyl Health · 2021 - 2024

Diabetic Retinopathy

ResearchPrincipal Investigator · Awarded by Retinal Care Inc. · 2021 - 2023

Considering Patient Preferences in Chronic Cough

ResearchPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2020 - 2023

Rescuing Kidneys at Risk of Discard

ResearchPrincipal Investigator · Awarded by Northwestern University · 2019 - 2023

Astellas Prostate Cancer - Part 2 DECIDER

ResearchPrincipal Investigator · Awarded by Astellas Pharma Inc. · 2021 - 2023

Patient-Centered Treatment Labeling in Depression

ResearchPrincipal Investigator · Awarded by Lundbeck, Inc. · 2021 - 2022

Benefit Risk Tradeoffs Associated with PRO for PAD

ResearchCo Investigator · Awarded by Food and Drug Administration · 2020 - 2022

Caregivers Survey

ResearchPrincipal Investigator · Awarded by Lundbeck, Inc. · 2021 - 2022

Treatment Switching Behavior among Multiple Myeloma Patients

ResearchPrincipal Investigator · Awarded by Amgen, Inc. · 2018 - 2021

Patient Preference Information: Bridging Regulatory Decisions and Clinical Practice

ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2018 - 2021

Preference Tx for Sequencing in NSCLC

ResearchPrincipal Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2018 - 2021

Stated Therapy Preferences of Child Caregivers and Adult Patients with Peanut Allergy

ResearchCo Investigator · Awarded by Aimmune Therapeutics · 2018 - 2020

Immunoglobulin Therapies Based on Treatment Experience

ResearchPrincipal Investigator · Awarded by Grifols USA, LLC · 2017 - 2020

Quatifying Patient Preferences for Heart Failure Interventions

ResearchCo Investigator · Awarded by Medical Device Innovation Consortium · 2019 - 2020

Meningitis B Vaccine European study

ResearchCo Investigator · Awarded by Pfizer, Inc. · 2018 - 2020

Pediatric Crohn's Disease Patient and Provider Risk-Benefit Preferences for Monotherapy versus Combination Therapy

ResearchInvestigator · Awarded by University of Pennsylvania · 2015 - 2018

External Relationships


  • BioMarin Pharmaceutical, Inc.
  • Duke-NUS Medical school
  • Google LLC
  • Innovation and Value Initiative
  • Novartis pharmaceuticals
  • US Food and Drug Administration
  • World Bank
  • YourCareChoice

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.